| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -57.33M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EWTX returned +197.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +78.0% |
| 1 year | +197.5% |
| 5 years | +178.9% |
| All-time high | $44.18 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in EWTX would be worth today ›No. Edgewise Therapeutics, Inc. has not paid a dividend in the past 12 months.
Edgewise Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol EWTX.
Edgewise Therapeutics, Inc. is part of the Healthcare sector.
Edgewise Therapeutics, Inc. has a market cap of 4.80B USD, based on the latest quote.
Edgewise Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.